MoveDMD Trial: Catabasis Provides Update (February 2017) The Catabasis team spoke to our community on February 2, 2017 to discuss what they learned from this latest trial and what comes next in the MoveDMD program. Research & Clinical Trial Webinars,Webinars 8 years ago You may also like 50:18 Roche/Genentech Anti-Myostatin Adnectin RG6206 in Duchenne (May 2018) 6 years ago Research & Clinical Trial Webinars,Webinars 49:43 NS Pharma’s Exon 53 Skipping Program Update (April 2018) 7 years ago Research & Clinical Trial Webinars,Webinars 1:01:32 Gene Therapy: A Closer Look (March 2018) 7 years ago Research & Clinical Trial Webinars,Webinars gene therapy 1:02:50 Pulmonary Care in Adults with Duchenne (March 2018) 7 years ago Care Webinars,Webinars 50:27 Positive Data from Summit’s PhaseOUT DMD Ezutromid Clinical Trial (February 2018) 7 years ago Research & Clinical Trial Webinars,Webinars 53:55 Italfarmaco Provides Givinostat Update (January 2018) 7 years ago Research & Clinical Trial Webinars,Webinars 1:05:47 Understanding Gene Therapy, Part 3 – Galgt2 and Dup2 (December 2017) 7 years ago Research & Clinical Trial Webinars,Webinars gene therapy 50:36 Capricor Therapeutics’ HOPE-Duchenne Clinical Trial (November 2017) 7 years ago Research & Clinical Trial Webinars,Webinars «1…1516171819…25»Page 17 of 25
by: Parent Project Muscular Dystrophy
